Surgical Correction of Moderate Ischemic Mitral Regurgitation

Completed

• Conditions: Moderate Ischemic Mitral Regurgitation

• Registration Number: NCT00394797
• Lead Sponsor: Shaare Zedek Medical Center

Brief Summary

The purpose of this study is to try and determine whether repair of moderate ischemic mitral regurgitation at the time of coronary bypass graft surgery (CABG) has an impact on survival.We will compare patients undergoing CABG + mitral repair or CABG only groups. Primary endpoints include late survival. Secondary endpoints include event free survival, symptoms, and echocardiographic outcomes.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2006-10-31
• Study First Submitted QC: 2006-10-31
• Study First Posted: 2006-11-01
• Status Verified: 2011-05
• Last Update Submitted: 2011-05-31
• Last Update Posted: 2011-06-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• patients undergoing coronary bypass surgery who have moderate degree of ischemic MR

Exclusion Criteria

• etiology of mitral regurgitation other than ischemic, degree of regurgitation other than moderate.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
survival at 1,5 and 10 years

Secondary Outcome Measures

Name	Time	Method
event free survival
echocardiographic parameters
symptoms

Trial Locations

Locations (1)

Shaare Zedek Medical Center; 🇮🇱 Jerusalem, Israel